GlassScriptPhysician profile
Justice Otchere
NPI 1073957932
$20,810.76
in general payments reported to CMS, 2019-2025
26 companies · $4,249 in 2025
The $4,249 reported for 2025 was more than what 93% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,679 · 2020: $1,833 · 2021: $1,664 · 2022: $2,968 · 2023: $2,907 · 2024: $4,511 · 2025: $4,249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,667.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $9,004.71 | 2019-2025 | Proclaim, Eterna, Octrode |
| Biotronik Nro, INC. | $3,306.29 | 2023-2025 | Prospera, Biotronik |
| Globus Medical, INC. | $2,349.39 | 2025 | Senza, Omnia, Vyrsa V1 |
| Nevro Corp. | $1,274.05 | 2021-2024 | Senza |
| Vertiflex, INC. | $1,230.72 | 2019 | |
| Nalu Medical, INC. | $1,230.23 | 2024-2025 | Nalu Neurostimulation System |
| Boston Scientific Corporation | $807.82 | 2020-2025 | Infinion 16, Linear, Infinion 16 |
| Medtronic, INC. | $320.39 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $186.33 | 2021-2024 | Relistor |
| Painteq LLC | $158.33 | 2021-2023 | Painteq |
| Vertos Medical, INC. | $153.24 | 2020-2024 | Mild Device Kit |
| Relievant Medsystems, INC. | $150.68 | 2022-2023 | Intracept |
| Mml US, INC. | $148.00 | 2025 | Reactiv8 |
| Allergan, INC. | $100.64 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $68.62 | 2024-2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $63.03 | 2022-2025 | Prolate, Tanlor, Nalocet |
| Scilex Pharmaceuticals INC. | $40.80 | 2022 | |
| Medtronic USA, INC. | $35.91 | 2020 | |
| Spr Therapeutics, INC | $34.45 | 2025 | Sprint Pns System |
| Curonix LLC | $33.37 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Convatec INC. | $24.56 | 2024 | |
| Alkermes, INC. | $21.99 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $20.05 | 2022 | |
| Redhill Biopharma INC. | $19.63 | 2020 | |
| Amneal Pharmaceuticals LLC | $14.58 | 2023 | Lyvispah |
| Pfizer INC. | $12.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justice Otchere listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.